, , , , , , , ,

Smith & Nephew‘s Exclusive OXINIUM Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japan

OXINIUM Oxidized Zirconium, the patented advanced bearing material from Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedics Division, has been awarded a C1 premium reimbursement classification in Japan for use in hipreplacement surgery.

The decision by the Central Medical Insurance Committee comes three years after it awarded Smith & Nephew with Japan’s first-ever premium price reimbursement for an orthopaedic implant—for the use of OXINIUM material in total knee replacement implants. Smith & Nephew is the only orthopaedic medical device company to have been awarded C1 reimbursement for both hip and knee replacement implants.

Read more: http://www.benzinga.com/news/11/02/874065/smith-nephews-exclusive-oxinium-material-for-hip-replacement-implants-chosen-for-p#ixzz1TIdTnk7t